Cath-L-dBET1

CAT: 0804-HY-173257Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-173257Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Cath-L-dBET1 is a PROTAC degrader targeting BRD4. Cath-L-dBET1 has an IC50 value of 2.8 μM in MDA-MB-231 cells. Cath-L-dBET1 can be activated by cathepsin L (Cath-L) and recruit the E3 ubiquitin ligase and degrade BRD4 through ubiquitin-proteasome system. Hyp-dBET1 can be used for anti-tumor study[1].
UNSPSC
12352005
Target
Epigenetic Reader Domain; PROTACs
Related Pathways
Epigenetics; PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
CC1=C(C)C(C(C2=CC=C(Cl)C=C2)=N[C@H]3CC(NCCCCN(C(COC4=C5C(C(N(C6C(NC(CC6)=O)=O)C5=O)=O)=CC=C4)=O)CC7=CC=C(NC([C@@H](NC(OC(C)(C)C)=O)CCCCNC(C)=O)=O)C=C7)=O)=C(S1)N8C3=NN=C8C
Molecular Formula
C58H66ClN11O11S
Molecular Weight
1160.73
References & Citations
[1]Dutta R, et al. Dual-Action-Only PROTACs. J Am Chem Soc. 2025 Mar 19;147 (11) :9074-9078.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-101838-01DBET1
HY-173256Hyp-dBET1
HY-173255DAO-dBET1
HY-P4071OH-CATH
HY-P11120NA-CATH
HY-P10431Hc-CATH
HY-P5724Nv-CATH
HY-W928653L-Seryl-L-leucyl-L-leucyl-L-lysine
HY-101552A-01L, L-Dityrosine
HY-P4621-01L-Alanyl-L-alanyl-L-glutamine

Alternative Products

CatalogName
T206243-01Cath-L-dBET1
BUP12837-01DBET1
A16858-10DBET1 10mg
A16858-50DBET1 50mg
T206694-01DAO-dBET1
A16858-2DBET1 2mg
A16858-5DBET1 5mg
A16858-25DBET1 25mg
A16858-1DBET1 1mg
A16858-100DBET1 100mg

Popular Products